Biovica: Secures fourth work order from existing pharma client - Redeye

Biovica announced this morning an expanded work order within its Pharma Services division from a clinical-stage biopharmaceutical company. The unnamed client, currently developing a next-generation CDK inhibitor for solid tumors, is expanding the collaboration after seeing promising initial TKa biomarker findings in its ongoing Phase I program.

Länk till analysen i sin helhet: https://www.redeye.se/research/1169452/biovica-secures-fourth-work-order-from-existing-pharma-client?utm_source=finwire&utm_medium=RSS